Trial intelligence / Profile preview

FeNO-guided montelukast and prednisolone trial in chronic cough

2015-001736-38Phase 4Terminated

Sponsor
Hull University Teaching Hospitals
Start
Sep 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of montelukast and prednisolone in chronic cough (3 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Change in 24-hour cough counts. Started Sep 2015; status: terminated.

02

Drugs

montelukastprednisolone
03

Conditions

chronic cough

Beyond the preview

Go deeper on 2015-001736-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001736-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call